Mergers and Acquisitions Within the Biotech Industry Expected to Rise in 2013

Five Star Equities Provides Stock Research on ISIS Pharmaceuticals and Threshold Pharmaceuticals

Continue Reading

Merger and Acquisition Activity Expected to Rise in 2013 as Big Pharma Companies Flush With Cash

Five Star Equities Provides Stock Research on Biosante Pharmaceuticals and Cell Therapeutics

Continue Reading

Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013

Five Star Equities Provides Stock Research on Achillion Pharmaceuticals and Dendreon

Continue Reading

Baltic Dry Index Posts First Increase Since November as Iron Ore Shipments on the Rise

Five Star Equities Provides Stock Research on Navios Maritime Holdings and Paragon Shipping

Continue Reading

Shipping Stocks on an Impressive Run to Start the Year as Baltic Dry Index Shows Signs of Bottoming Out

Five Star Equities Provides Stock Research on Diana Shipping and Frontline

Continue Reading

Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry-s Success in 2012

Five Star Equities Provides Stock Research on Inovio Pharmaceuticals and Rexahn Pharmaceuticals

Continue Reading

DryShips and Eagle Bulk Shipping Shares Soar as Baltic Dry Index Rises for the First Time Since November

Five Star Equities Provides Stock Research on DryShips and Eagle Bulk Shipping

Continue Reading

Baltic Dry Index Posts First Increase Since November as Iron Ore Shipments on the Rise

Five Star Equities Provides Stock Research on Genco Shipping & Trading and Excel Maritime Carriers

Continue Reading

Fiscal Cliff Legislation Extends Alternative Fuels Tax Credits Through 2013

Five Star Equities Provides Stock Research on Archer Daniels Midland and Pacific Ethanol

Continue Reading

Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry-s Success in 2012

Five Star Equities Provides Stock Research on Navidea Biopharmaceuticals and NuPathe

Continue Reading